NASDAQ · NXTC

NextCure, Inc.

Closing price · Nov 13, 2026 $6.40

Latest quarter · ended Sep 30, 2026

Cash got weaker

descriptionFiled Nov 10, 2026
Cash from operationsWorse
−$12.1M
Quarter ended Dec 31, 2024: −$6.97M cash from operationsQuarter ended Mar 31, 2025: −$13M cash from operationsQuarter ended Jun 30, 2025: −$22.7M cash from operationsQuarter ended Sep 30, 2025: −$6.27M cash from operationsQuarter ended Dec 31, 2025: −$7.64M cash from operationsQuarter ended Mar 31, 2026: −$13.4M cash from operationsQuarter ended Jun 30, 2026: −$9.71M cash from operationsQuarter ended Sep 30, 2026: −$12.1M cash from operations
Dec '24Sep '26
vs. −$6.27M a year ago
Share countDiluting
+70.9%
Quarter ended Dec 31, 2024: 28.01M sharesQuarter ended Mar 31, 2025: 28.05M sharesQuarter ended Jun 30, 2025: 2.68M sharesQuarter ended Sep 30, 2025: 2.68M sharesQuarter ended Dec 31, 2025: 3.56M sharesQuarter ended Mar 31, 2026: 3.61M sharesQuarter ended Jun 30, 2026: 4.58M sharesQuarter ended Sep 30, 2026: 4.58M shares
Dec '24Sep '26
4.58M shares vs. 2.68M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Selling Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 −38
  • account_balance
    1 fund bought, 7 sold in the quarter ended Jun 30, 2026, counting funds that hold 500 stocks or fewer and $1M+ of this one. Index funds and banks are left out.
  • info
    1 real insider sale in 12 months. $185K in total, not counting planned sales.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

30 funds report owning NXTC, up from 23

Holdings as of Jun 30, 2026
New14
Added6
Held6
Trimmed4
Sold out7

Last quarter

Who bought and who sold

Apr–Jun 2026

Change in shares held from Mar 31 to Jun 30, 2026, biggest holdings first. Only funds that hold 500 stocks or fewer and $1M+ of this one: index funds and banks own almost everything, so their changes say little. Bars stop at ±100%.

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovOpen-market sale · Aug 10 · $185K
CEOCFOOther officersDirectorsJunJulAugSepOctNovOpen-market sale · Aug 10 · $185K

Last 6 months. A wider screen shows 12.

Showing 1 real trade. Bigger dot means a bigger trade.

Real trades, newest first

Aug 10 Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd. Officer Open-market sale $185K 30,000 sh at $6.16 Sold 9% of stake

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in NXTC

As of Jun 30, 2026

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist